ILMN  valuation analysis

Name: Illumina Inc
Description: Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Nov 04, 2021
Market cap: $57.96B (140th)
Sales(TTM): $4.28B (533rd)
Earnings(TTM): $907.00M (323rd)

FFER: 3.46 (why)
Actual price: $378.80
FFEThis is Illumina Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $109.46
Quantile: ILMN is very expensive given its fundamentals.
Prices as of EOD 2021-12-22
Price & Estimates
Sales & Earnings history (TTM)
  • Illumina Inc's sales grew by 32.2% ($3.24B to $4.28B) over one year against a market average growth of 16.3%.
  • Illumina Inc's operating income decreased from $715.00M to -$32.00M in the last year.
Earnings / MarketCap
Illumina Inc
"Diagnostics & Research" industry
Sales / MarketCap
Illumina Inc
"Diagnostics & Research" industry
Book / MarketCap
Illumina Inc
"Diagnostics & Research" industry
Equity / Assets
Illumina Inc
"Diagnostics & Research" industry